TransMedics Group, Inc.
TMDX
$87.72
-$0.52-0.59%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 241.70% | 191.22% | 116.87% | 63.98% | 30.92% |
| Total Depreciation and Amortization | 141.63% | 201.91% | 196.58% | 162.85% | 135.11% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -19.91% | -28.70% | 229.75% | 255.23% | 251.73% |
| Change in Net Operating Assets | -1.47% | -11.49% | -33.80% | -128.36% | -65.73% |
| Cash from Operations | 474.60% | 247.61% | 172.36% | 78.37% | 71.57% |
| Capital Expenditure | 14.56% | -40.04% | -2,618.10% | -1,692.96% | -1,175.28% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 102.96% | 102.96% | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 100.00% | -198.32% | -150.44% | -140.97% |
| Cash from Investing | 33.33% | -1.69% | -1,419.21% | -650.70% | -455.79% |
| Total Debt Issued | -- | -100.00% | -100.00% | 686.20% | 686.20% |
| Total Debt Repaid | -- | 100.00% | 100.00% | -44.44% | -44.44% |
| Issuance of Common Stock | 221.72% | 144.43% | -89.11% | -95.75% | -95.11% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 100.00% | 100.00% | -- | -- |
| Cash from Financing | -94.29% | -94.38% | -97.12% | 133.06% | 138.45% |
| Foreign Exchange rate Adjustments | -377.72% | 24.79% | -53.85% | 92.95% | 118.90% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -130.04% | -143.57% | -139.80% | -13.02% | 10.27% |